Results 291 to 300 of about 1,506,029 (346)

Harm Reduction Strategies for People Who Use Drugs.

JAMA
This JAMA Patient Page describes harm reduction strategies for people who use drugs, which include testing for drug contaminants, overdose prevention, and reducing risk of infectious disease transmission.
Rebecca A Voelker
semanticscholar   +6 more sources

“If I had them, I would use them every time”: Perspectives on fentanyl test strip use from people who use drugs

Journal of Substance Abuse Treatment, 2022
INTRODUCTION Fentanyl contamination in the illicit drug supply has contributed to a significant increase in overdose deaths in the United States. Fentanyl test strips (FTS), which can detect the presence of fentanyl in drugs, are increasingly given to ...
Megan K Reed, Venise J Salcedo, Kristin L Rising   +2 more
exaly   +2 more sources

Health risks associated with smoking versus injecting fentanyl among people who use drugs in California.

Drug and Alcohol Dependence, 2023
BACKGROUND Given the attention, funding, and services that seek to reduce overdose mortality from fentanyl, it is important to understand whether a potential solution is for more people to switch from injecting to smoking fentanyl. As such, we set out to
Cariné E. Megerian, L. Bair, Jessica Smith, Erica N. Browne, L. Wenger, L. Guzman, A. Kral, B. Lambdin   +7 more
semanticscholar   +1 more source

People who use drugs, HIV, and human rights

The Lancet, 2010
We reviewed evidence from more than 900 studies and reports on the link between human rights abuses experienced by people who use drugs and vulnerability to HIV infection and access to services. Published work documents widespread abuses of human rights, which increase vulnerability to HIV infection and negatively affect delivery of HIV programmes ...
Ralf, Jürgens, Joanne, Csete, Joseph J, Amon, Stefan, Baral, Chris, Beyrer   +4 more
openaire   +2 more sources

Interventions to reduce self-stigma in people who use drugs: A systematic review.

Journal of substance use and addiction treatment, 2023
BACKGROUND Substance use stigma is a key barrier to treatment and harm reduction engagement among people who use drugs (PWUD). Previous systematic reviews have focused on interventions to reduce stigma in healthcare providers and the public; less is ...
Adams L. Sibley, David C Colston, Vivian F Go   +2 more
semanticscholar   +1 more source

Experiences of stigmatization among people who use drugs in the initial year of British Columbia's drug decriminalization policy: A qualitative study.

The International journal on drug policy
BACKGROUND On January 31, 2023, Health Canada approved a three-year pilot decriminalization initiative allowing adults in British Columbia (BC), Canada, to legally possess a cumulative 2.5 g of opioids, cocaine, methamphetamine, or MDMA.
Farihah Ali, Cayley Russell, Savannah Torres-Salbach, Margret Lo, Matt Bonn, G. Bardwell, Juls Budau, Elaine Hyshka, Jürgen Rehm   +8 more
semanticscholar   +1 more source

Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study

Social Science & Medicine (1967)
Background: In 2020, 2.8 million people required substance use disorder (SUD) treatment in nonmetropolitan or ‘rural’ areas in the U.S. Among this population, only 10% received SUD treatment from a specialty facility, and 1 in 500 received medication for
T. Stopka, A. Estadt, G. Leichtling, J. Schleicher, L. Mixson, J. Bresett, E. Romo, P. Dowd, S. Walters, A. Young, B. Zule, P. D. Friedmann, V. Go, R. Baker, R. Fredericksen   +14 more
semanticscholar   +1 more source

A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine are Urgently Needed in the Fentanyl Era.

Journal of addiction medicine, 2022
With the worst opioid overdose death crisis in the United States history, urgent new approaches to assist people who use drugs onto medication for opioid use disorder are necessary.
Kimberly L Sue, Shawn M Cohen, Jess Tilley, Avi Yocheved   +3 more
semanticscholar   +1 more source

Xylazine-Associated Wounds and Related Health Concerns Among People Who Use Drugs: Reports From Front-Line Health Workers in 7 US States

Substance use & addiction journal
Background: Xylazine, an adrenergic alpha-2 agonist increasingly present in the US drug supply, is associated with severe skin ulcers and other harms. Expert knowledge from front-line harm reduction and healthcare professionals is an essential component ...
Jennifer J. Carroll
semanticscholar   +1 more source